Lexaria Bioscience CorpScience and partner Altria complete Phase One of the development program Transcript

Jul 17, 2020 / NTS GMT
Steve Darling - Proactive Vancouver - Analyst

Welcome back inside our Proactive newsroom. And joining me now is Chris Bunka, the CEO of Lexaria Bioscience. And Chris, it's great to have you back. How are you doing?

Chris Bunka - Lexaria Bioscience Corp. - Chairman & CEO

I'm really well, Steve, how are you today?

Steve Darling - Proactive Vancouver - Analyst

Doing very well. So lots of stuff to talk about. You put out a news release that you had completed Phase 1 of your development program that you were doing with Altria.

Questions and Answers:

Steve Darling - Proactive Vancouver - Analyst

So maybe we can take a step back and maybe tell me a little bit about this partnership with Altria and what Phase 1 really consisted of?

Chris Bunka - Lexaria Bioscience Corp. - Chairman & CEO

Fair. So Altria, of course, is the one of the largest tobacco companies in the world. They are the owner of the Marlboro franchise in the
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot